Torrent Group

The Mehta family controls investment decisions through a governance structure where second-generation principals Samir and Sudhir Mehta retain oversight, while third-generation family members execute operating-level capital allocation. Strategic M&A decisions, including the JB Pharma buyout and the Gujarat Titans acquisition, are driven by the family core with professional transaction support.

Torrent Group operates through two publicly listed flagship companies — Torrent Pharmaceuticals (BSE: 500420) and Torrent Power (BSE: 532779) — alongside unlisted entities for newer ventures like the Gujarat Titans franchise. The pharma and power divisions generate the bulk of operating cash flow, which feeds both reinvestment into the core businesses and the family's unlisted investment activities.

Torrent has not publicly disclosed an exclusion list, but the observable investment pattern shows no known exposure to financial services, pure-play technology, metals, or heavy industrials. The group concentrates in pharmaceuticals, energy, and — with the Gujarat Titans acquisition — consumer-facing sports media, with no indication of genuine diversification outside these pillars.

Torrent transacted with both firms as a buyer. In 2023, it acquired a controlling stake in JB Chemicals & Pharmaceuticals from KKR. In 2025, it acquired a majority stake in the Gujarat Titans IPL franchise from CVC Capital Partners. These were arm's-length acquisitions; neither CVC nor KKR holds a disclosed ongoing partnership or co-investment relationship with Torrent.